Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TYCHE INDUSTRIES vs BLISS GVS PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TYCHE INDUSTRIES BLISS GVS PHARMA TYCHE INDUSTRIES/
BLISS GVS PHARMA
 
P/E (TTM) x 15.8 14.3 110.8% View Chart
P/BV x 1.9 1.5 131.5% View Chart
Dividend Yield % 0.9 0.4 223.2%  

Financials

 TYCHE INDUSTRIES   BLISS GVS PHARMA
EQUITY SHARE DATA
    TYCHE INDUSTRIES
Mar-23
BLISS GVS PHARMA
Mar-23
TYCHE INDUSTRIES/
BLISS GVS PHARMA
5-Yr Chart
Click to enlarge
High Rs16391 178.2%   
Low Rs10567 156.0%   
Sales per share (Unadj.) Rs73.572.2 101.9%  
Earnings per share (Unadj.) Rs13.87.4 187.7%  
Cash flow per share (Unadj.) Rs15.69.2 169.8%  
Dividends per share (Unadj.) Rs2.000.50 400.0%  
Avg Dividend yield %1.50.6 237.0%  
Book value per share (Unadj.) Rs113.984.0 135.6%  
Shares outstanding (eoy) m10.25104.15 9.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.81.1 165.6%   
Avg P/E ratio x9.710.8 89.9%  
P/CF ratio (eoy) x8.68.7 99.4%  
Price / Book Value ratio x1.20.9 124.5%  
Dividend payout %14.56.8 213.1%   
Avg Mkt Cap Rs m1,3728,262 16.6%   
No. of employees `000NANA-   
Total wages/salary Rs m70862 8.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m7547,516 10.0%  
Other income Rs m48178 27.1%   
Total revenues Rs m8027,694 10.4%   
Gross profit Rs m1601,173 13.7%  
Depreciation Rs m18187 9.5%   
Interest Rs m0104 0.0%   
Profit before tax Rs m1911,061 18.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m49293 16.7%   
Profit after tax Rs m142767 18.5%  
Gross profit margin %21.315.6 136.2%  
Effective tax rate %25.727.7 93.1%   
Net profit margin %18.810.2 184.1%  
BALANCE SHEET DATA
Current assets Rs m1,2196,974 17.5%   
Current liabilities Rs m2101,933 10.9%   
Net working cap to sales %133.967.1 199.6%  
Current ratio x5.83.6 161.1%  
Inventory Days Days1339 32.5%  
Debtors Days Days1,0691,871 57.1%  
Net fixed assets Rs m1924,562 4.2%   
Share capital Rs m102104 98.4%   
"Free" reserves Rs m1,0658,646 12.3%   
Net worth Rs m1,1688,750 13.3%   
Long term debt Rs m0407 0.0%   
Total assets Rs m1,41111,535 12.2%  
Interest coverage x19,085.011.2 169,876.1%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.50.7 82.0%   
Return on assets %10.07.6 133.0%  
Return on equity %12.18.8 138.4%  
Return on capital %16.312.7 128.6%  
Exports to sales %57.90-   
Imports to sales %19.90-   
Exports (fob) Rs m437NA-   
Imports (cif) Rs m150NA-   
Fx inflow Rs m4375,618 7.8%   
Fx outflow Rs m1611,225 13.2%   
Net fx Rs m2754,394 6.3%   
CASH FLOW
From Operations Rs m68343 19.9%  
From Investments Rs m19-78 -25.1%  
From Financial Activity Rs m-15-249 6.2%  
Net Cashflow Rs m7230 239.3%  

Share Holding

Indian Promoters % 62.0 35.0 177.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 21.3 -  
FIIs % 0.0 14.7 -  
ADR/GDR % 0.0 0.0 -  
Free float % 38.0 65.0 58.5%  
Shareholders   7,867 45,157 17.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TYCHE INDUSTRIES With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on TYCHE INDUSTRIES vs BLISS GVS PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

TYCHE INDUSTRIES vs BLISS GVS PHARMA Share Price Performance

Period TYCHE INDUSTRIES BLISS GVS PHARMA S&P BSE IT
1-Day 1.27% 5.15% 0.10%
1-Month 20.94% 10.65% -3.37%
1-Year 21.95% 60.79% 27.91%
3-Year CAGR -2.70% 4.74% 9.37%
5-Year CAGR 26.63% -6.38% 16.49%

* Compound Annual Growth Rate

Here are more details on the TYCHE INDUSTRIES share price and the BLISS GVS PHARMA share price.

Moving on to shareholding structures...

The promoters of TYCHE INDUSTRIES hold a 62.0% stake in the company. In case of BLISS GVS PHARMA the stake stands at 35.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of TYCHE INDUSTRIES and the shareholding pattern of BLISS GVS PHARMA.

Finally, a word on dividends...

In the most recent financial year, TYCHE INDUSTRIES paid a dividend of Rs 2.0 per share. This amounted to a Dividend Payout ratio of 14.5%.

BLISS GVS PHARMA paid Rs 0.5, and its dividend payout ratio stood at 6.8%.

You may visit here to review the dividend history of TYCHE INDUSTRIES, and the dividend history of BLISS GVS PHARMA.

For a sector overview, read our software sector report.



Today's Market

HCL Tech Q4 Results | Maruti Suzuki Declares Dividend | Top Buzzing Stocks Today HCL Tech Q4 Results | Maruti Suzuki Declares Dividend | Top Buzzing Stocks Today(Pre-Open)

Indian share markets reversed the trend as the session progressed and ended the lower. After starting higher on Friday, equity markets had an anti-climatic end today.